Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.

Autores de IIS La Fe

• Eva Polverino

  Autor

• Carles Agusti Garcia-Navarro

  Autor

• Beatriz Montull Veiga

  Autor

• Rosario Menéndez Villanueva

  Autor

• Antonio Torres Marti

  Autor

Participantes ajenos a IIS La Fe

• Cillóniz C
• Dambrava P
• Gabarrús A
• Ferrer M
• Prina E
• Niederman MS

Grupos

• Infecciones Respiratorias

Abstract

Although the benefits of systemic corticosteroids in community-acquired pneumonia (CAP) are not clear, their use is frequent in clinical practice. We described the frequency of this practice, patients' characteristics and its clinical impact.

Keywords

• adjunctive therapy; clinical stability; community-acquired pneumonia; mortality; systemic corticosteroid